Household net worth is a major and overlooked factor in adherence to hormonal therapy among breast cancer patients and partially explains racial disparities in quality of care.
A CUMC study found that the use of generic aromatase inhibitors, which cost considerably less than their brand-name counterparts, increased treatment adherence by 50 percent.
Radiation exposure from breast cancer treatment is associated with a small risk of developing heart disease later in life, but the risk is now lower than it was 20 years ago.
Columbia's Wendy Chung, the original plaintiff in the case against Myriad Genetics, says the Supreme Court decision banning gene patents will open a new era of genomic medicine.
Dr. Robert Klitzman applauded Jolie's prophylactic breast cancer surgery but says it raises moral questions about gene patents.